Solana Co — Director's Dealing 2020

Jun 16, 2020

SEC Form 4/A — Form 4/A

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-06-10

Reporting Person: Walter Blane (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-10	Stock Option (Right to Buy)	$0.545	A	61218	Acquired	2030-06-09	Class A Common Stock (61218)	Direct

Footnotes

F1: This Form 4/A is being filed to amend an inadvertent error in the number of stock options granted to the Reporting Person in the Form 4 previously filed on June 12, 2020. The number of stock options reported on this amendment reflect the correct number of stock options granted to and held by the Reporting Person.

F2: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continued service through each applicable vesting date.